p38 MAPK inhibitor SB203580 enhances anticancer activity of PARP inhibitor olaparib in a synergistic way on non-small cell lung carcinoma A549 cells
Article in Biochemical and Biophysical Research Communications (May 2023)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Article in Biochemical and Biophysical Research Communications (May 2023)
Article in Phytomedicine Plus (February 2023)
Article in American Journal of Cancer Research (January 2023)